Three groups targeting Orchid Pharma’s assets

The Economic Times has reported today that three companies have stepped forward to acquire the assets of India-based Orchid Pharma, currently in bankruptcy proceedings and with a debt of as much as INR35bn ($537m). The three bids have been submitted by Fidelity Trading Corporation, IngenCapital e Union Quimico Farmacéutica.

(Source: The Economic Times)